Literature DB >> 18803393

Selection of aptamers against live bacterial cells.

Camille L A Hamula1, Hongquan Zhang, Le Luo Guan, Xing-Fang Li, X Chris Le.   

Abstract

Single-stranded DNA or RNA aptamer molecules have usually been selected against purified target molecules. To eliminate the need of purifying target molecules on the cell surface, we have developed a selection technique using live bacterial cells in suspension as targets, to select for ssDNA aptamers specific to cell surface molecules. Lactobacillus acidophilus cells were chosen to demonstrate proof of principle based on their high abundance of surface molecules (potential targets). Aptamer pools obtained after 6-8 rounds of selection demonstrated high affinity for and selective binding with L. acidophilus cells when tested via flow cytometry, microscopy, and fluorescence measurements. Out of 27 aptamers that were cloned and sequenced, one sequence, hemag1P, was found to bind to L. acidophilus much more strongly and specifically than other cells tested. This aptamer was predicted to have a tight hairpin secondary structure. On average, an estimated 164 +/- 47 aptamer molecules were bound to a target cell with an apparent K d of 13 +/- 3 nM. A likely putative molecular target of hemag1P is the S-layer protein on the cell surface.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803393     DOI: 10.1021/ac801272s

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  30 in total

1.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  A novel screening method for competitive FRET-aptamers applied to E. coli assay development.

Authors:  John G Bruno; Maria P Carrillo; Taylor Phillips; Carrie J Andrews
Journal:  J Fluoresc       Date:  2010-05-05       Impact factor: 2.217

Review 3.  Recent developments in protein and cell-targeted aptamer selection and applications.

Authors:  Jun Liu; Mingxu You; Ying Pu; Huixia Liu; Mao Ye; Weihong Tan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Authors:  Erik W Orava; Aws Abdul-Wahid; Eric H-B Huang; Amirul Islam Mallick; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-04-11       Impact factor: 6.603

Review 5.  Molecular aptamers for drug delivery.

Authors:  Weihong Tan; Hui Wang; Yan Chen; Xiaobing Zhang; Haizhen Zhu; Chaoyong Yang; Ronghua Yang; Chen Liu
Journal:  Trends Biotechnol       Date:  2011-08-06       Impact factor: 19.536

Review 6.  Promising new assays and technologies for the diagnosis and management of infectious diseases.

Authors:  S F Mitsuma; M K Mansour; J P Dekker; J Kim; M Z Rahman; A Tweed-Kent; P Schuetz
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

Review 7.  Development of hydrogels for regenerative engineering.

Authors:  Xiaofei Guan; Meltem Avci-Adali; Emine Alarçin; Hao Cheng; Sara Saheb Kashaf; Yuxiao Li; Aditya Chawla; Hae Lin Jang; Ali Khademhosseini
Journal:  Biotechnol J       Date:  2017-02-21       Impact factor: 4.677

8.  Plastic-adherent DNA aptamer-magnetic bead and quantum dot sandwich assay for Campylobacter detection.

Authors:  John G Bruno; Taylor Phillips; Maria P Carrillo; Randy Crowell
Journal:  J Fluoresc       Date:  2008-12-04       Impact factor: 2.217

9.  A PDMS/paper/glass hybrid microfluidic biochip integrated with aptamer-functionalized graphene oxide nano-biosensors for one-step multiplexed pathogen detection.

Authors:  Peng Zuo; XiuJun Li; Delfina C Dominguez; Bang-Ce Ye
Journal:  Lab Chip       Date:  2013-10-07       Impact factor: 6.799

10.  Enrichment of cancer cells using aptamers immobilized on a microfluidic channel.

Authors:  Joseph A Phillips; Ye Xu; Zheng Xia; Z Hugh Fan; Weihong Tan
Journal:  Anal Chem       Date:  2009-02-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.